Oslo, Norway, 8 February 2022
Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022. Vistin Pharma will host a conference call for all shareholders and interested parties on Thursday 17th of February at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in English.
The fourth quarter conference call will be available via web and audio through the following access points:
Telephone conference:
Confirmation Code:…….. 7590346
International dial-In:…….. +44 (0) 2071 928338
Norway, Oslo:……………. +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.com/mmc/p/jb9o62eq
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…
The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…
MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:…
TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…
TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…